<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; green</title>
	<atom:link href="http://www.tapanray.in/tag/green/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>China Coronavirus And API Sourcing &#8211; A Threat… Or An Opportunity For India?</title>
		<link>http://www.tapanray.in/china-coronavirus-and-api-sourcing-a-threat-or-an-opportunity-for-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=china-coronavirus-and-api-sourcing-a-threat-or-an-opportunity-for-india</link>
		<comments>http://www.tapanray.in/china-coronavirus-and-api-sourcing-a-threat-or-an-opportunity-for-india/#comments</comments>
		<pubDate>Mon, 03 Feb 2020 00:00:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2019-nCoV]]></category>
		<category><![CDATA[Active]]></category>
		<category><![CDATA[API]]></category>
		<category><![CDATA[bulk]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[green]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[ingredients]]></category>
		<category><![CDATA[Kerala]]></category>
		<category><![CDATA[opportunity]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[repurposing]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[shoots]]></category>
		<category><![CDATA[sourcing]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[threat]]></category>
		<category><![CDATA[Vaccine]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9858</guid>
		<description><![CDATA[‘2015 – Year of Active Pharmaceutical Ingredients’ (API), announced the Government of India by a Press Release on February 25, 2015. This came after ascertaining that over-dependence on imports of bulk drugs or API, especially from China, is detrimental to India’s health &#8230; <a href="http://www.tapanray.in/china-coronavirus-and-api-sourcing-a-threat-or-an-opportunity-for-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/china-coronavirus-and-api-sourcing-a-threat-or-an-opportunity-for-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Visible, The Green Shoots of Digital Transformation in Pharma</title>
		<link>http://www.tapanray.in/visible-the-green-shoots-of-digital-transformation-in-pharma/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=visible-the-green-shoots-of-digital-transformation-in-pharma</link>
		<comments>http://www.tapanray.in/visible-the-green-shoots-of-digital-transformation-in-pharma/#comments</comments>
		<pubDate>Mon, 22 Jul 2019 00:00:54 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[CDO]]></category>
		<category><![CDATA[Chief]]></category>
		<category><![CDATA[company]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[digitization]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[green]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Internet of Things]]></category>
		<category><![CDATA[IoT]]></category>
		<category><![CDATA[Officer]]></category>
		<category><![CDATA[rationalization]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulated]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[shoots]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[temporary]]></category>
		<category><![CDATA[transformation]]></category>
		<category><![CDATA[warming-up]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9636</guid>
		<description><![CDATA[Currently, one gets a mixed feeling about the progress of digital transformation in the pharma industry. This is despite various reports confirming that a number of major initiatives in this field have been taken, especially by Big Pharma, globally. Moreover, &#8230; <a href="http://www.tapanray.in/visible-the-green-shoots-of-digital-transformation-in-pharma/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/visible-the-green-shoots-of-digital-transformation-in-pharma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma And Healthcare: Mounting ‘Trust Deficit’ In Post Halcyon Days</title>
		<link>http://www.tapanray.in/pharma-and-healthcare-mounting-trust-deficit-in-post-halcyon-days/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-and-healthcare-mounting-trust-deficit-in-post-halcyon-days</link>
		<comments>http://www.tapanray.in/pharma-and-healthcare-mounting-trust-deficit-in-post-halcyon-days/#comments</comments>
		<pubDate>Mon, 01 Sep 2014 00:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[American]]></category>
		<category><![CDATA[BMJ]]></category>
		<category><![CDATA[CCI]]></category>
		<category><![CDATA[clinical trial]]></category>
		<category><![CDATA[deficit]]></category>
		<category><![CDATA[disillusionment]]></category>
		<category><![CDATA[Doctored]]></category>
		<category><![CDATA[George Wilhelm Herman Emanuel Merck]]></category>
		<category><![CDATA[green]]></category>
		<category><![CDATA[harsh]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Healthcheck]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[Jauhar]]></category>
		<category><![CDATA[kickbacks]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[MCI]]></category>
		<category><![CDATA[Merck & Co]]></category>
		<category><![CDATA[Minister]]></category>
		<category><![CDATA[Moody]]></category>
		<category><![CDATA[mounting]]></category>
		<category><![CDATA[NDTV]]></category>
		<category><![CDATA[operation]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[shoots]]></category>
		<category><![CDATA[sting]]></category>
		<category><![CDATA[Sundeep]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[trust]]></category>
		<category><![CDATA[unbothered]]></category>
		<category><![CDATA[Vardhan]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=5795</guid>
		<description><![CDATA[Although a radical transformation in the field of medicine and path breaking advances of medical sciences are in progress, the healthcare system as whole, including the pharma industry, as voiced by many, is fast losing its human touch and values. &#8230; <a href="http://www.tapanray.in/pharma-and-healthcare-mounting-trust-deficit-in-post-halcyon-days/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-and-healthcare-mounting-trust-deficit-in-post-halcyon-days/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>IPR, Climate Change and addressing the issue of transfer of Carbon abatement technology in the developing world.</title>
		<link>http://www.tapanray.in/ipr-climate-change-and-addressing-the-issue-of-transfer-of-carbon-abatement-technology-in-the-developing-world/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ipr-climate-change-and-addressing-the-issue-of-transfer-of-carbon-abatement-technology-in-the-developing-world</link>
		<comments>http://www.tapanray.in/ipr-climate-change-and-addressing-the-issue-of-transfer-of-carbon-abatement-technology-in-the-developing-world/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 01:30:50 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abatement]]></category>
		<category><![CDATA[addressing]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Carbon]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Climate]]></category>
		<category><![CDATA[Developing]]></category>
		<category><![CDATA[green]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[transfer]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=718</guid>
		<description><![CDATA[To address all pervasive global challenge of climate change, access to efficient and cost effective carbon abatement technology to reduce the greenhouse effect has become a very important issue, especially for an emerging economy like, India. This issue perhaps will &#8230; <a href="http://www.tapanray.in/ipr-climate-change-and-addressing-the-issue-of-transfer-of-carbon-abatement-technology-in-the-developing-world/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/ipr-climate-change-and-addressing-the-issue-of-transfer-of-carbon-abatement-technology-in-the-developing-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
